Bridging Preclinical to Clinical Development - A Swiss Biotech Insight Event

Leveraging Proven Strategies for Holistic Biomarkers, Advanced Modalities and Technology Insights​

📍 Agora Cancer Research Centre Lausanne

In this Insight series event, the Swiss Biotech Association joins forces with Labcorp to explore key learnings from biomarker-informed development, showcase cutting-edge analytical technologies for enhanced data collection and interpretation, and examine the integration of multi-omics approaches—all through the lens of real-world experience and case studies that support smarter decision-making.

Program

11:30 – 13:00 Registration and networking lunch

13:00 – 14:00 Welcome and opening session

• Michael Altofer, CEO, Swiss Biotech Association
• Julia Djonova, Head of the Advanced Therapy Medicinal Products (ATMP) department, Swissmedic
• Stefano Romanelli, Senior Government Affairs Manager, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

14:00 – 15:15 Discovery to preclinical innovation: Setting the scientific foundation

• Dan Snell, SVP Research & Preclinical Development, Numab
• Giusy Di Conza, Head of Research, Ionctura
• Stephanie Jungmichel, Head of Pharmacology, CDR Life
• James Munday, Head Global Immunology & Immunotoxicology, Labcorp

15:45 – 17:15 Strategy & clinical execution: Linking science to business impact

• Shabir Hasham, Chief Medical Officer, Santhera
• Frédéric Levy, Chief Scientific Officer, Debiopharm
• Rebecca Weil, Chief Commercial Officer, Oculis
• Alex Fort, Lead Scientist, General laboratory, Labcorp

17:15 – 18:30 Networking cocktail